Elevated anticardiolipin antibodies in autoimmune haemolytic anaemia irrespective of underlying systemic lupus erythematosus

Abstract

In patients with systemic lupus erythematosus (SLE) and concomitant Coombs positive autoimmune haemolytic anaemia (AIHA) anticardiolipin antibodies (aCL) are found more frequently and at higher titres than in SLE patients without AIHA. In order to assess if aCL elevation is primarily associated with the underlying SLE, or with AIHA itself, we examined AIHA patients with and without underlying SLE for the presence of aCL.

aCL (IgG and IgM) were determined by ELISA in 74 SLE patients without AIHA, 22 SLE patients with AIHA, 50 patients with idiopathic AIHA (warm-reactive autoantibodies), 52 patients with idiopathic AIHA (cold-reactive autoantibodies) and 50 healthy controls.

The mean IgG and IgM aCL titres in SLE patients without AIHA (IgG 37.0 U/ml, IgM 8.9 U/ml) were significantly elevated compared with the values in healthy controls (IgG 9.1 U/ml, IgM 3.2 U/ ml; P < 0.005). The mean aCL levels in SLE patients with AIHA (IgG 53.2 U/ml, IgM 28.2 U/ml) were higher than in SLE patients without AIHA (P = 0.09 for IgG, P < 0.005 for IgM). Interestingly, the mean aCL levels of patients with idiopathic AIHA (warm-reactive autoantibody type: IgG 29.2 U/ml, IgM 19.3 U/ml; cold-reactive autoantibody type: IgG 27.4 U/ml, IgM 18.9 U/ ml) were also significantly elevated compared with healthy controls P < 0.001).

As aCL are elevated not only in SLE (with and without concomitant AIHA) but also in idiopathic AIHA it can be speculated that aCL are involved in the pathomechanism of autoantibody-induced erythrocyte destruction per se irrespective of an underlying SLE.

Keywords

anticardiolipin antibodies autoimmune haemolytic anaemia systemic lupus erythematosus

Get full access to this article

View all access options for this article.

References

Hughes Grv. Thrombosis, abortion, cerebral disease and lupus anticoagulant. Br Med J 1983; 287: 1088-1089.

Harris EN et al. Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in SLE. Lancet 1983; 2: 1211-1214.

Harris EN , Gharavi AE , Hughes Grv. The anticardiolipin syndrome. J Rheumatol 1986; 13: 486-488.

Fort JG et al. Anticardiolipin antibodies in patients with rheumatic diseases . Arthritis Rheum 1987; 30: 752-760.

Alarcon-Segovia D. et al. Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. A prospective analysis of 500 consecutive patients. Medicine 1989 ; 68: 353-365.

Love PE , Santoro SA Antiphospholid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Ann Intern Med 1990; 112: 682-698.

Hughes Grv. The antiphospholid syndrome. Ten years on. Lancet 1993; 342: 341-344.

Canoso RT , Sise HS Chlorpromazine induced lupus anticoagulant and associated immunologic abnormalities . Am J Hematol 1982; 13: 121-129.

Manoussakis MN et al. High prevalence of anticardiolipin and other autoantibodies in a healthy elderly population. Clin Exp Immunol 1987; 69: 557-565.

10.

Santiago MB et al. Anticardiolipin antibodies in patients with infectious diseases. Clin Rheumatol 1989 ; 8: 23-28.

11.

Dostal C. et al. Anticardiolipin antibodies in infectious mononucleosis. J Rheumatol 1990; 17: 1573-1574 (letter).

12.

Maneta-Peyret LM et al. Autoantibodies against all phospholipids: a comparative systematic study with systemic lupus erythematosus and healthy sera. Eur J Clin Chem Clin Biochem 1991; 29: 39-43.

13.

Faiderbe S. , Chagnaud JL , Geffard M. A monoclonal anti-idiotypic antibody with an internal image of a 'phosphatidylinositol-like' structure derived from anti-'phosphatidylinositol-like' IgG from sera of patients with proliferative malignancy. Int J Cancer 1993; 53: 285-289.

14.

Becker JC et al. Antiphospholipid syndrome associated with immunotherapy for patients with melanoma. Cancer 1994; 73: 1621-1624.

15.

Wang Y. et al. Antiphospholipid antibodies in systemic lupus erythematosus: clinical and laboratory associations in 111 patients Rheumatol Int 1990; 10: 75-80.

16.

Gulko PS et al. Anticardiolipin antibodies in systemic lupus erythematosus: clinical correlates, HLA associations, and impact on survival. J Rheumatol 1993; 20: 1684-1693.

17.

Loizou S. et al. Association of quantitative anticardiolipin antibody levels with fetal loss in systemic lupus erythematosus. Q J Med 1988; 255: 525-531.

18.

Sachse C. et al. Significance of antibodies to cardiolipin in unselected patients with systemic lupus erythematosus: clinical and laboratory associations. Rheumatol Int 1995; 15: 23-29.

19.

Kutteh WH et al. Association of anticardiolipin antibodies and pregnancy loss in women with systemic lupus erythematosus. Fertil Steril 1993; 60: 449-455.

20.

Harris EN et al. Thrombocytopenia in SLE and related autoimmune disorders: association with anticardiolipin antibodies. Br J Haematol 1985; 59: 227-230.

21.

Fong KY et al Anticardiolipin antibodies, haemolytic anaemia and thrombocytopenia in systemic lupus erythematosus. Br J Rheumatol 1992; 31: 453-455.

22.

Hughes Grv , Asherson RA , Khamashta MA The antiphospholipid syndrome: from theory to discovery. Postgrad Med J 1989; 65: 691-704.

23.

Alarcon-Segovia D. , Cabral AR

Antiphosphoipid antibodies. Where do they come from? Where do they go?

J Rheumatol 1994 ; 21: 982-989.

24.

Aron AL , Gharavi AE , Shoenfeld Y. Mechanisms of action of antiphospholipid antibodies in the antiphospholipid syndrome. Int Arch Allergy Immunol 1995; 106: 8-12.

25.

Hazeltine M. et al. Antiphospholipid antibodies in systemic lupus erythematosus: evidence of an association with positive Coombs' and hypocomplementemia. J Rheumatol 1988; 15: 80-86.

26.

Deleze M. , Oria CV , Alarcon-Segovia D. Occurrence of both hemolytic anemia and thrombocytopenia purpura (Evans' syndrome) in systemic lupus erythematosus. Relationship to antiphospholipid antibodies . J Rheumatol 1988; 15: 611-615.

27.

Deleze M. et al. Hemocytopenia in systemic lupus erythematosus. Relationship to antiphospholipid antibodies. J Rheumatol 1989; 16: 926-930.

28.

Sthoeger Z. et al. The role of anticardiolipin autoantibodies in the pathogenesis of autoimmune hemolytic anemia in systemic lupus erythematosus . J Rheumatol 1993; 20: 2058-2061.

29.

Tan EM et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 15: 1271-1277.

30.

Cabral AR , Cabiedes J. , Alarcon-Segovia D. Hemolytic anemia related to an IgM autoantibody to phosphatidylcholine that binds in vitro to stored and to bromelain-treated human erythrocytes. J Autoimmun 1990; 3: 773-787.

31.

Guzman J. et al. Antiphospholipid antibodies in patients with idiopathic autoimmune haemolytic anemia. Autoimmunity 1994; 18: 51-65.

32.

Del Papa N. et al. Antiphospholipid antibodies cross-reacting with erythrocyte membranes. A case report. Clin Exp Rheumatol 1992; 10: 395-399.

33.

Arvieux J. et al. Autoimmune haemolytic anaemia due to antiphospholipid antibodies . Vox Sang 1991; 61: 190-195.

34.

Cheng HM IgG antiphospholipid autoantibody in normal human sera is reactive against bromelain treated human erythrocytes. J Rheumatol 1993; 20: 400 (letter).

35.

Arnold LW , Haughton G. Autoantibodies to phosphatidylcholine. The murine antibromelain RBC response . Ann NY Acad Sci 1992; 651: 354-359.

36.

Arvieux J. et al. Erythrocyte binding of antiphospholipid antibodies. Clin Exp Rheumatol 1993; 11: 352-353 (letter).